The integration of artificial intelligence (AI) into ultrasound imaging is rapidly transforming diagnostic workflows across healthcare. From handheld devices in emergency settings to advanced systems in radiology suites, the momentum behind AI in ultrasound imaging is driven by a convergence of technology, clinical need and economic pressures. With rising patient volumes, chronic disease burdens and an imperative for faster, more accurate diagnoses, stakeholders are increasingly turning to AI-powered ultrasound solutions.
In this article we explore the current state of the AI in ultrasound imaging market, its segmentation, regional dynamics, key players, and how these forces are aligning to drive the next wave of medical-imaging innovation. The focus on AI in ultrasound diagnostics reflects a broader shift in imaging: from passive capture to real-time interpretation, aided by machine learning, computer vision and natural language processing.
Market Snapshot and Growth Drivers
Market Size & Forecast
The AI in ultrasound imaging market is expected to grow significantly over the coming years. Specifically:
The Artificial Intelligence in Ultrasound Imaging Market was valued at USD 966.45 Million in 2024 and is forecast to reach USD 1,883.72 Million by 2032, representing a compound annual growth rate (CAGR) of 8.7% during 2025-2032. This expansion is driven largely by the mounting prevalence of chronic and lifestyle diseases worldwide.
Why Growth Is Accelerating
Several forces underpin this growth:
The global incidence of cancer, cardiovascular disease and diabetes is increasing. For example, the International Agency for Research on Cancer reported approximately 19.3 million new cancer cases in 2020 with nearly 10 million related deaths; this is projected to grow by 47% by 2040.
Cardiovascular diseases account for about 32% of global deaths, according to the World Health Organization.
The International Diabetes Federation estimates the global diabetic population may reach 783 million by 2045.
As incidence of these diseases climbs, healthcare systems face rising demand for fast, accurate diagnostics and efficient workflows.
In this context, AI in ultrasound imaging offers a compelling solution: enabling faster scans, improved anomaly detection, less operator-dependency and higher throughput. For hospitals and diagnostic centres, this represents a means to manage increasing patient loads while maintaining quality and cost-effectiveness.
Quick Stats for Artificial Intelligence in Ultrasound Imaging Market Size Analysis:
2024 valuation: USD 966.45 million
2032 projection: USD 1,883.72 million
Forecast CAGR (2025-2032): ~8.7%
Primary growth drivers: rising chronic disease burden, workflow efficiency demand, advanced imaging tools
Get Insights into Market Movements: Request a Sample Report: https://www.snsinsider.com/sample-request/3076
Segmentation of the Market
By Technology
Machine Learning: Core segment driving the market, responsible for pattern recognition, anomaly detection and predictive insights.
Computer Vision: Enables automated image interpretation, segmentation and measurement.
Natural Language Processing (NLP): Used in report generation and integration of imaging insights with clinical records.
Others: Context-aware computing and hybrid AI models.
By Application
Radiology: Broad use across general imaging, tumour detection and organ monitoring.
Obstetrics & Gynecology: AI assists in fetal monitoring, anomaly detection and growth tracking.
Cardiovascular: Automated strain analysis, chamber quantification and vascular imaging.
Others: Musculoskeletal, oncology, urology and point-of-care scenarios.
By End User
Hospitals: Largest revenue contributors, leveraging enterprise imaging systems and institutional workflows.
Patients: Indirectly benefit through improved outcomes and faster diagnostics.
Healthcare Payers: Drive value-based adoption and reimbursement models.
Others: Diagnostic imaging centres, outpatient clinics, ambulatory surgical centres.
Regional Analysis & Coverage
North America (US, Canada): Leads the global market with strong infrastructure, favourable reimbursement, and high adoption of advanced imaging technologies.
Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe): Mature healthcare systems with growing investment in AI-driven diagnostics.
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific): Fastest growth region due to rising healthcare spending, growing diagnostic networks and government initiatives.
Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of MEA): Opportunity markets with increasing imaging investments and unmet diagnostic demand.
Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America): Emerging region where cost-effective AI ultrasound solutions can address access challenges.
Key Company Profiles
Major players shaping the AI in ultrasound imaging market include:
IBM
NVIDIA Corporation
Intel Corporation
Microsoft
Samsung Medison
Butterfly Network
GE Healthcare
Siemens Healthineers
Canon Medical Systems
EchoNous Inc.
General Vision
Enlitic Inc.
Imagia Cybernetics Inc.
Agfa‑Gevaert Group
CloudMedx Inc.
Micron Technology Inc.
Philips Healthcare
Caption Health
Koios Medical
MaxQ AI
These companies are deploying strategies such as AI algorithm development, partnerships with hospitals and imaging centres, expansion into point-of-care ultrasound, and leveraging cloud and edge workflows.
Middle Section
The Artificial Intelligence in Ultrasound Imaging Market Size was valued at USD 966.45 Million in 2024 and is expected to reach USD 1,883.72 Million by 2032 and grow at a CAGR of 8.7% over the global forecast period of 2025-2032. The growing prevalence of lifestyle and chronic diseases within the global population is mainly driving the demand for AI-back ultrasound imaging. This trend is reflected in alarming health statistics. According to the International Agency for Research on Cancer, in 2020 nearly 19.3 million new cases of cancer were detected worldwide, and almost 10 million deaths were related to cancer. These numbers are estimated to grow by 47% by 2040, hence the immense need for more precise diagnostic tools. Cardiovascular diseases also amount to around 32% of world deaths based on the review of the World Health Organization (WHO). International Diabetes Federation also projects that the total global diabetic population is going to hike up to 783 million by 2045.
As incidence levels of chronic diseases continue ascending, so does the urgency for healthcare systems to dispense quick and effective service. More imperative in this regard is the potential of advanced technologies such as AI in ultrasound imaging. It will thus be easier for healthcare providers to perform faster examinations with a greater degree of accuracy, hence quicker diagnosis and higher-quality patient outcomes directly result. This technology is expected to have a big impact in light of mitigating the burden of the hospitals, hence making effective management of increasing numbers of hospital admissions and chronic disease patients. Therefore, this ultrasound imaging AI take-up shall increase multifold in the coming years ahead.
Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends: https://www.snsinsider.com/reports/artificial-intelligence-in-ultrasound-imaging-market-3076
Emerging Trends & Innovations
Several key trends are reshaping how AI in ultrasound imaging will evolve:
Shift to Point-of-Care Ultrasound (POCUS): Handheld and portable AI-enabled ultrasound devices are enabling real-time scanning outside of traditional radiology, including emergency, ICU and remote settings.
Workflow Automation & Efficiency Gains: AI tools increasingly automate image segmentation, view selection and measurement—reducing operator dependency and scan time while improving consistency.
Cloud & Edge Integration: AI algorithms are being deployed both on-device and via cloud platforms to enable remote interpretation, tele-ultrasound and decentralized diagnostics.
Expanding Applications: While obstetrics, cardiology and general radiology lead today, AI in ultrasound is expanding into musculoskeletal, oncology, vascular and neonatal imaging.
Software-First Models: Many vendors are prioritising software platforms and algorithm licensing (rather than hardware) to address legacy systems and broadly scale AI deployments.
Value-Based Care & Reimbursement Pressure: Healthcare providers are seeking technologies that help reduce diagnostic error, expedite care and lower costs—making AI-driven ultrasound a strategic advantage.
These trends align to create a favourable environment for growth in the AI ultrasound imaging segment.
Opportunities & Challenges
Opportunities:
In emerging markets (Asia Pacific, Latin America, Middle East & Africa), there is significant unmet diagnostic imaging capacity and rising healthcare infrastructure spending, representing fertile ground for AI ultrasound solutions.
The ageing population globally and the increasing incidence of chronic diseases such as cardiovascular disease, cancer and diabetes ensure a steady demand for advanced diagnostic imaging.
Integrating AI ultrasound with telemedicine, remote monitoring and patient-centric models creates new pathways for service delivery—and new revenue streams for vendors.
Challenges:
High acquisition cost of AI-enabled ultrasound systems and software may restrain adoption, especially in lower-income settings.
Data security, patient privacy concerns, and algorithm transparency (the so-called “black box” issue) can hinder clinician trust and regulatory acceptance.
Need for interoperability with existing imaging infrastructure and workflow integration remains a significant barrier.
Training and change-management for sonographers and clinicians is required to optimise AI-augmented systems.
Careful market positioning, strategic partnerships and clear demonstration of clinical and economic value will be key to overcoming these challenges.
Why It Matters Now
For healthcare providers, technology vendors and investors, the AI in ultrasound imaging market represents a timely opportunity. Diagnostic imaging is becoming increasingly central to disease management, while resources (staff, time, equipment) remain constrained. AI-augmented ultrasound has the potential to deliver:
Faster time to diagnosis
Improved accuracy and consistency
Greater accessibility (especially in underserved settings)
Better patient outcomes and workflow cost reduction
With credible market forecasts projecting nearly doubled valuation by 2032, and the clinical imperatives already in place, stakeholders are wise to pay attention now. Early movers may gain competitive advantage, while laggards risk being out-paced by more efficient diagnostic workflows.
Conclusion
The artificial intelligence in ultrasound imaging market is poised for substantive growth as the convergence of chronic disease burden, imaging demand and technological innovation aligns. With a forecast of USD 1,883.72 Million by 2032 (CAGR ~8.7%), and numerous emerging applications from cardiology to obstetrics to point-of-care, the opportunity is clear.
For hospitals, implementing AI-augmented ultrasound can improve diagnostic throughput, reduce dependency on specialised staff and enhance patient outcomes. For vendors and technology developers, the challenge will be to deliver interoperable, cost-effective solutions that integrate seamlessly into clinical workflows and deliver measurable value.
As regulatory frameworks, reimbursement models and clinician acceptance evolve, the market is expected to mature rapidly—those who act now may set the standard for next-gen imaging diagnostics. The time for AI in ultrasound imaging is here.
Related Report:
Geographic Atrophy (GA) Market
Frequently Asked Questions (FAQ)
Q1: What is the current market size of AI in ultrasound imaging?
A1: The market was valued at approximately USD 966.45 Million in 2024.
Q2: What is the expected market size by 2032?
A2: The market is projected to reach around USD 1,883.72 Million by 2032, with a CAGR of about 8.7% from 2025-2032.
Q3: What are the main technology segments within this market?
A3: Key segments include machine learning, computer vision, natural language processing and other emerging AI technologies.
Q4: Which end-user segment dominates the market?
A4: Hospitals currently dominate the market, due to their imaging volume, infrastructure investment and central role in advanced diagnostics.
Q5: What drives adoption of AI in ultrasound imaging?
A5: The major drivers include rising chronic disease prevalence, demand for faster and more accurate diagnostics, workflow efficiency imperatives and expansion of point-of-care imaging.
